Schwartz Jonathan David 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Sale
Common Stock
2025-11-18$2.98/sh−2,545$7,592→ 299,064 total
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.